270 related articles for article (PubMed ID: 17821917)
21. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study.
Tzourmakliotis D; Economou M; Manolakopoulos S; Bethanis S; Bergele C; Lakoumentas J; Sclavos P; Milionis H; Margeli A; Vogiatzakis E; Avgerinos A
Scand J Gastroenterol; 2004 Dec; 39(12):1180-5. PubMed ID: 15742993
[TBL] [Abstract][Full Text] [Related]
22. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
[TBL] [Abstract][Full Text] [Related]
23. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
Sostres C; Carrera-Lasfuentes P; Benito R; Roncales P; Arruebo M; Arroyo MT; Bujanda L; García-Rodríguez LA; Lanas A
Am J Gastroenterol; 2015 May; 110(5):684-9. PubMed ID: 25895518
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for presentation with bleeding in patients with Helicobacter pylori-related peptic ulcer diseases.
Hsu PI; Lai KH; Tseng HH; Lin CK; Lo GH; Cheng JS; Chan HH; Chen GC; Jou HS; Peng NJ; Ger LP; Chen W; Hsu PN
J Clin Gastroenterol; 2000 Jun; 30(4):386-91. PubMed ID: 10875466
[TBL] [Abstract][Full Text] [Related]
25. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
26. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
27. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption.
Manguso F; Riccio E; de Nucci G; Aiezza ML; Amato G; Degl'Innocenti L; Piccirillo MM; De Dominicis G; Santoro T; Trimarco E; Balzano A
World J Gastroenterol; 2011 Oct; 17(40):4509-16. PubMed ID: 22110282
[TBL] [Abstract][Full Text] [Related]
29. [Helicobacter pylori and non-steroidal anti-inflammatory agents].
Knoflach P
Acta Med Austriaca; 2000; 27(4):126-8. PubMed ID: 10989682
[TBL] [Abstract][Full Text] [Related]
30. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding.
Wu CY; Poon SK; Chen GH; Chang CS; Yeh HZ
Scand J Gastroenterol; 1999 Mar; 34(3):234-7. PubMed ID: 10232865
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of acute upper gastrointestinal bleeding.
van Leerdam ME
Best Pract Res Clin Gastroenterol; 2008; 22(2):209-24. PubMed ID: 18346679
[TBL] [Abstract][Full Text] [Related]
32. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
33. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
[TBL] [Abstract][Full Text] [Related]
34. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
Cullen DJ; Hawkey GM; Greenwood DC; Humphreys H; Shepherd V; Logan RF; Hawkey CJ
Gut; 1997 Oct; 41(4):459-62. PubMed ID: 9391242
[TBL] [Abstract][Full Text] [Related]
35. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
[TBL] [Abstract][Full Text] [Related]
36. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
Hawkey CJ
Gut; 2000 Mar; 46(3):310-1. PubMed ID: 10673289
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.
Lanas A
Postgrad Med; 2005 Jun; 117(6):23-8, 31. PubMed ID: 16001765
[TBL] [Abstract][Full Text] [Related]
38. [Clinical characteristics of non-steroidal anti-inflammatory drugs associated gastroduodenal ulcer bleeding].
Zhang L; Lu YM; Ding SG; Liao ZL
Zhonghua Nei Ke Za Zhi; 2003 Apr; 42(4):258-60. PubMed ID: 12887811
[TBL] [Abstract][Full Text] [Related]
39. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
Zullo A; Hassan C; Campo SM; Morini S
Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
Santolaria S; Lanas A; Benito R; Pérez-Aisa Mf; Montoro M; Sainz R
Aliment Pharmacol Ther; 1999 Nov; 13(11):1511-8. PubMed ID: 10571609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
